drugset / Trial / NCT03633747

Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma

NCT03633747

NaSingle-groupOpen-labelTreatment

Summary

Hepatic hemangioma is one of the most common benign tumor of the liver. Although the overall prognosis is good, active interventions are still needed in high-risk patients. Without specific drugs, the main treatment methods include surgical treatments, interventional therapies and radiotherapies. Effective medical treatments are needed urgently. Propranolol has achieved good results in infantile Facial/hepatic hemangioma, and shows some effectiveness in adult hemangioma. Here, investigators intend to evaluate the therapeutic effect of propranolol in adult hepatic hemangioma.

Timeline

Start
2018-07-01
Primary completion
2020-08-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 1.5 mg/kg Oral

Indications